JPRN-UMIN000013972已完成未知
Effect of iron-contained phosphate binder on serum FGF23 in hemodialysis patients. - Effect of iron-contained phosphate binder on serum FGF23 in hemodialysis patients.
Ojiya general hospital0 个研究点目标入组 30 人开始时间: 2014年5月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •excess of iron
研究者
相似试验
已完成
4 期
Iron containing phosphate binder and iron metabolismChronic kidney diseaseJPRN-jRCTs051190013Kuragano Takahiro64
未知
不适用
Effect of iron containing phosphate binder on iron metabolism of patients undergoing maintenance hemodialysis.Chronic kidney diseaseJPRN-UMIN000023700Hyogo College of Medicine300
已完成
不适用
Efficacy of the iron-based phosphate binder in patients on peritoneal dialysis.chronic renal failureJPRN-UMIN000034472Saiseikai Yokohamashi Tobu Hospital100
已完成
Unknown
The effect of novel iron-containing phosphate binder,ferric citrate, to serum P,Ca,and iron metabolic markers on HD patients.HD PatientsJPRN-jRCT1090220207Shigeru Miyazaki20
已完成
不适用
Evaluation for new Phosphate Iron-based binder , Sucroferric Oxyhydroxide in Dialysis patient for E.B.MhyperphosphatemiaJPRN-UMIN000023648Osaka University Graduate School of Medicine Department of Nephrology200